| Literature DB >> 33260585 |
Gabriela Bairán1, Georgette Rebollar-Pérez2, Edith Chávez-Bravo1, Eduardo Torres1.
Abstract
Advances generated in medicine, science, and technology have contributed to a better quality of life in recent years; however, antimicrobial resistance has also benefited from these advances, creating various environmental and health problems. Several determinants may explain the problem of antimicrobial resistance, such as wastewater treatment plants that represent a powerful agent for the promotion of antibiotic-resistant bacteria (ARB) and antibiotic resistance genes (ARG), and are an important factor in mitigating the problem. This article focuses on reviewing current technologies for ARB and ARG removal treatments, which include disinfection, constructed wetlands, advanced oxidation processes (AOP), anaerobic, aerobic, or combined treatments, and nanomaterial-based treatments. Some of these technologies are highly intensive, such as AOP; however, other technologies require long treatment times or high doses of oxidizing agents. From this review, it can be concluded that treatment technologies must be significantly enhanced before the environmental and heath problems associated with antimicrobial resistance can be effectively solved. In either case, it is necessary to achieve total removal of bacteria and genes to avoid the possibility of regrowth given by the favorable environmental conditions at treatment plant facilities.Entities:
Keywords: advance oxidation processes; electrochemistry; microbial resistance; ozonation; photocatalysis; treatment technologies
Year: 2020 PMID: 33260585 PMCID: PMC7730199 DOI: 10.3390/ijerph17238866
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1General mechanisms of antimicrobial resistance (Elaborated from references [10] and [11]).
Figure 2Determinants in the antimicrobial resistance problem.
Examples of microorganisms found in different wastewater treatment plants.
| Microorganism or Resistant Strain | Resistance Profile | Water Sample | Country or Place | Reference |
|---|---|---|---|---|
|
| Penicillin G, Ampicillin, Vancomycin, Erythromycin, Triple sulfa, and Trimethoprim /sulfamethoxazole | Influent and effluent from wastewater treatment plant (WWTPs) | Germany | [ |
| Trimethoprim, rifampin, chloramphenicol | Influent, effluent wastewater treatment | Michigan, USA. | [ | |
| Ampicillin, Tetracycline, Erythromycin | Influent and effluent, as well as in the aeration chamber and in the return activated sludge mixture | Poland | [ | |
| Multi-resistant | Affluent treatment plant | USA | [ | |
| Multi-resistant | Non-chlorinated effluent | USA | [ | |
| Resistance genes | Sulfonamide(sul), | Crude affluent, Primary clarifier tank, Anaerobic tank. | China | [ |
| Bacterial isolates resistant to tetracycline ( | Multi-resistant | Wastewater from the secondary treatment process of three WWTPs | Toronto | [ |
| Enterococos | Multi-resistant | Primary effluent, final effluent, and biomass. | Canada | [ |
| Ciprofloxacin, Cotrimoxazole, Ampicillin, and Trimethoprim | Affluent and Effluent from the WWTP | City of Sneek, The Netherlands | [ | |
|
| Ampicillin, Cefazolin, and Ceftriaxone | Sludge from a WWTP | Taizhou, China | [ |
| Multi-resistant | Affluent and effluent | Florida | [ | |
|
| Amoxicillin, ciprofloxacin, norfloxacin, kanamycin, sulfamethoxazole/trimethoprimand tetracycline | Sludge in the aeration tank and return sludge | Japan | [ |
| Resistance genes | Sulfonamides (sul1), tetracycline (tetM) and polymixin (mcr-1) and of the class 1 integrase gene (intI1) | 16 different European effluents of WWTPs | Europe | [ |
| Resistance genes | Tetracycline (tet A, B, C, G, L, M, O, Q, X) and sulfonamide (sulI, sulII, sulIII) | Raw influent and final effluent samples | Poland | [ |
| Resistance genes | Chloramphenicol (catA1); sulfonamides (sul I); tetracycline (tetE); aminoglycoside (aac (3)) -IV; penicillins bla TEM, bla CTX-M, bla NDM-1 | Pharmaceutical wastewaters | Nigeria | [ |
| Resistance genes | Sulfonamides (sul1, sul2), tetracycline (tetW, tetQ, tetX) | Activated sludge | China | [ |
| The extended-spectrum beta-lactamase (ESBL)-producing | Ampicillin, cefazolin, and ceftriaxone | Aerobic active sludge | Taizhou, China | [ |
| Resistance genes | Sulfonamides (sul1, sul2) | Effluent of secondary treatment in WWTPs | Europe, America, Asia, and Africa | [ |
|
| Tetracycline, Streptomycin, kanamycin, | Sewage influent of WWTPs | Japan | [ |
| Ciprofloxacin, nalidixic acid | Influents and effluents from WWTPs | Italy | [ | |
| Resistance genes | Tetracyclines (tetA, tetB, tetM, tetX), beta-lactams (blaTEM, blaSHV, blaOXA, blaCTX-M, blaCTX-M-1, blaCTX-2, blaCTX-M-9, blaVEB, blaCMY, blaAMP-C), chloramphenicol (florR, cmlA, fexA, fexB) | Samples of untreated wastewater and treated wastewater from 4 WWTPs | Poland | [ |
| Methicillin, vancomycin | Activated sludge bioreactor | Olsztyn, Poland | [ |
Categorization of treatment processes (adapted from references [67,68,69]).
| Category | Pathway or Mechanisms | Advantages/Drawbacks |
|---|---|---|
| Conventional wastewater treatment processes | A combination of physical (settling ponds), chemical (coagulation/flocculation), and biological processes (aerobic/anaerobic) | Acclimation of micro sludge fauna can lead to carrying antibiotic resistance to the environment |
| Tertiary and advanced treatment processes | Advanced separation techniques (membrane filtration, distillation, reverse osmosis, adsorption on activated carbon) | Membrane filtration or adsorption represents a transfer/concentration of pollutants to a matrix that is disposed of as solid residues |
| Advanced oxidation processes | Ozonation, Fenton oxidation, photocatalysis, plasma technology, ultrasonic technology | Good efficiency of antibiotic degradation/ Can generate unknown byproducts or more toxic than parent compounds |
| Hybrid treatments (combination of technologies) | Membrane bioreactors or use of synthetic biology such as enzymatic removal of active pharmaceutical ingredients | Good efficiency of antibiotic degradation/ Generation of unknown byproducts with an enzymatic process |
| Post conventional treatment processes | Constructed wetlands | Represents the concentration of antibiotics in soil or plant roots. Further studies on biodegradation mechanisms are needed. |
Examples of technologies treatment for antimicrobial resistance mitigation.
| Microorganism or Resistant Strain | Operating Conditions | Treatment | Country or Place | Reference |
|---|---|---|---|---|
| Resistance genes | Test thermophilic digesters were amended with environmentally relevant concentrations of Ag NP (0.01, 0.1, and 1.0 mg-Ag/L | Thermophilic anaerobic digesters | Virginia, USA | [ |
| Resistance genes | The anaerobic reactors at 37 °C, 46 °C, and 55 °C | Anaerobic reactors | Minnesota, USA | [ |
| Reaction time for disinfection is 180–240 and 90–120 min, respectively | Solar light and solar photo-Fenton processes | Switzerland | [ | |
| Resistance genes (tetA y bla TEM-1) | Photo-Fenton under visible LED and neutral pH conditions. | Photo-Fenton | Australia | [ |
| Resistance genes (sul1 y tetG) | Dose of 160 mg/L with a contact time of 120 min | Chlorination | China | [ |
| Resistance genes (sul1, tetX y tetG) | pH was 3.5 with an H2O2 concentration of 0.01mol/L accompanied by 30min of UV irradiation | UV/H2O2 process | China | [ |
|
| H2O2/TiO2/sunlight (cumulative energy per unit of volume (QUV) in the range 3–5 Kj/L | Disinfection and solar-driven advanced oxidation processes | Italy | [ |
| Current density from 7.14 mA/cm2 to 21.42 mA/cm2 and 120 min of treatment | Electrochemical | China | [ | |
| Bi2O2CO3 microspheres wrapped with nitrogen-doped reduced graphene oxide (NRGO) | Photocatalytic process | China | [ | |
|
| Ultrafiltration (UF) and nanofiltration (NF) membranes | Nano- and ultra-filtration processes | Norway | [ |
| UV dosage the 320 mJ/cm2 and dose chlorine 1–2 mg/L | Combined UV and chlorine process | China | [ | |
| Resistance genes | Surface flow, horizontal subsurface flow, and vertical subsurface flow and two Plant species (Thaliadealbata Fraser and Iris tectorum Maxim) | Constructed wetlands (CWs) | China | [ |
|
| High current pulsed irradiation of 280 nm LEDs | Pulsed UV-LED irradiation | China | [ |
| Resistance genes Sul1 | UV dose 432 mJ/cm2 and chlorine dosage 10 mg/L for small fragments and 40 mg/L for large fragments | Combined UV/free chlorine processes | Singapore | [ |
|
| 1 mg/L of ozone, with a contact time of 5 min | Ozone treatment | Germany | [ |
|
| Silver decorated graphene oxide (Ag/GO) composite and 60 min illumination | Nanomaterial-based treatments | China | [ |
| Resistance genes | Ventilated sludge drying reed bed | Wetlands | China | [ |
| Resistance genes | Free chlorine dosage of 30 mg/L with a 30-min contact time | Chlorination | Louisiana, USA | [ |
Figure 3Scheme for flow configuration, type of support, and type of macrophyte in the constructed wetlands.